LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.08 | 27.76 | 7 | 6849 | 0.0010 | -0.1592 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.08 | 27.76 | 6117 | 6849 | 0.8930 | 0.9717 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.08 | 27.76 | 791 | 6849 | 0.1155 | 0.5243 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.08 | 27.76 | 7393 | 6849 | 1.0793 | 1.0193 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 71.78 | 27.76 | 2 | 6893 | 0.0003 | -0.2815 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 71.78 | 27.76 | 6189 | 6893 | 0.8979 | 0.9731 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 71.78 | 27.76 | 814 | 6893 | 0.1181 | 0.5290 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 71.78 | 27.76 | 7631 | 6893 | 1.1070 | 1.0257 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 73.48 | 27.76 | 9 | 6957 | 0.0013 | -0.1318 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 73.48 | 27.76 | 6287 | 6957 | 0.9036 | 0.9747 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 73.48 | 27.76 | 788 | 6957 | 0.1133 | 0.5217 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 73.48 | 27.76 | 7812 | 6957 | 1.1228 | 1.0293 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 75.19 | 27.76 | 11 | 7015 | 0.0016 | -0.1095 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 75.19 | 27.76 | 6162 | 7015 | 0.8784 | 0.9678 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 75.19 | 27.76 | 750 | 7015 | 0.1069 | 0.5114 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 75.19 | 27.76 | 7971 | 7015 | 1.1363 | 1.0323 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.89 | 27.76 | 19 | 7025 | 0.0027 | -0.0464 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.89 | 27.76 | 5992 | 7025 | 0.8529 | 0.9605 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.89 | 27.76 | 764 | 7025 | 0.1088 | 0.5147 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.89 | 27.76 | 8178 | 7025 | 1.1641 | 1.0384 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.60 | 27.76 | 13 | 7045 | 0.0018 | -0.0906 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.60 | 27.76 | 5709 | 7045 | 0.8103 | 0.9480 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.60 | 27.76 | 835 | 7045 | 0.1185 | 0.5313 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.60 | 27.76 | 8326 | 7045 | 1.1817 | 1.0422 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.31 | 27.76 | 4 | 6976 | 0.0006 | -0.2157 | MN20160318_Q01 | C22 |